Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$197.69 - $227.29 $1,186 - $1,363
6 New
6 $1,000
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $856,358 - $945,676
-3,400 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$204.88 - $255.03 $20,488 - $25,503
-100 Reduced 2.86%
3,400 $867,000
Q1 2020

May 15, 2020

SELL
$104.32 - $195.28 $1,564 - $2,929
-15 Reduced 0.43%
3,500 $442,000
Q2 2019

Aug 13, 2019

SELL
$144.16 - $172.9 $2,450 - $2,939
-17 Reduced 0.48%
3,515 $608,000
Q4 2018

Feb 12, 2019

SELL
$120.82 - $174.09 $2,537 - $3,655
-21 Reduced 0.59%
3,532 $446,000
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $8,497 - $10,038
53 Added 1.51%
3,553 $638,000
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $523,145 - $561,960
3,500
3,500 $528,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.